Publicaciones en colaboración con investigadores/as de Erasmus University Medical Center (11)

2024

  1. Lipid-based nanosystems: the next generation of cancer immune therapy

    Journal of Hematology and Oncology, Vol. 17, Núm. 1

2022

  1. Stealth nanoparticles in oncology: Facing the PEG dilemma

    Journal of Controlled Release, Vol. 351, pp. 22-36

2021

  1. Drug transport kinetics of intravascular triggered drug delivery systems

    Communications Biology, Vol. 4, Núm. 1

  2. Dual activity of PD-L1 targeted Doxorubicin immunoliposomes promoted an enhanced efficacy of the antitumor immune response in melanoma murine model

    Journal of Nanobiotechnology, Vol. 19, Núm. 1

2020

  1. Sensitization of drug resistant sarcoma tumors by membrane modulation: Via short chain sphingolipid-containing nanoparticles

    Nanoscale, Vol. 12, Núm. 32, pp. 16967-16979

2019

  1. A new immune-nanoplatform for promoting adaptive antitumor immune response

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 17, pp. 13-25

  2. Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma response

    International Journal of Nanomedicine, Vol. 14, pp. 2069-2089

2017

  1. Cell membrane modulation as adjuvant in cancer therapy

    Cancer Treatment Reviews, Vol. 52, pp. 48-57

2016

  1. EGF-liposomes promote efficient EGFR targeting in xenograft colocarcinoma model

    Nanomedicine, Vol. 11, Núm. 5, pp. 465-477

  2. Targeting melanoma with immunoliposomes coupled to anti-MAGEAI TCR-like single-chain antibody

    International Journal of Nanomedicine, Vol. 11, pp. 955-975

2015

  1. Dosing algorithms for initiation of immunosuppressive drugs in solid organ transplant recipients

    Expert Opinion on Drug Metabolism and Toxicology, Vol. 11, Núm. 6, pp. 921-936